Author

J K Krefting

Observed name: J Krefting

Institutions: TUM Klinikum, Deutsches Herzzentrum München, Technical University of Munich

Observed institutions: TUM Klinikum, Deutsches Herzzentrum München, Technical University of Munich

OpenAlex ID: A5159553473

Plasma Infrared Fingerprinting Identifies Residual Risk in Coronary Artery Disease and Captures Clonal Haematopoiesis-Associated Biology

2026 · M von Scheidt, T Eissa, et al. · European Heart Journal

Colchicine modulates clonal hematopoiesis–associated inflammatory signaling in coronary artery disease: the COLCHIP trial

2026 · M von Scheidt, M Schwab, et al. · European Heart Journal

Atherosclerotic disease in adults with congenital heart disease (ACHD): High adverse event and comorbidity rates despite a favorable conventional risk factor profile

2026 · F von Scheidt, S Mahajan, et al. · European Heart Journal

Genetically modulated regulation of liver-derived MST1 links systemic inflammation to coronary artery disease risk

2026 · M Schwab, I P Pugach, et al. · European Heart Journal

Contemporary paediatric lipid percentiles in 5–14-year-olds: a population-based cross-sectional analysis

2026 · J Krefting, R Schmieder, et al. · European Heart Journal

Monogenic familial hypercholesterolaemia confers excess premature cardiovascular risk beyond LDL-C: a family-lineage and LDL-C–matched analysis

2026 · J Krefting, R Schmieder, et al. · European Heart Journal

Real-world efficacy and tolerability of lipid-lowering therapy in children with monogenic familial hypercholesterolemia in primary care

2026 · R S Schmieder, J Krefting, et al. · European Heart Journal

Works count: 7

Citation count:

H-index:

I10-index: